Avior Wealth Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10
| Closed | -$187 | – | 3448 |
|
|
2024
Q1 | $187 | Buy |
+10
| New | +$187 | ﹤0.01% | 2902 |
|
|
2021
Q1 | – | Sell |
-4,592
| Closed | -$397K | – | 1126 |
|
|
2020
Q4 | $397K | Sell |
4,592
-2,578
| -36% | -$223K | 0.05% | 311 |
|
|
2020
Q3 | $438K | Buy |
7,170
+450
| +7% | +$27.5K | 0.06% | 264 |
|
|
2020
Q2 | $279K | Buy |
6,720
+2,330
| +53% | +$96.7K | 0.04% | 340 |
|
|
2020
Q1 | $126K | Buy |
4,390
+1,890
| +76% | +$54.2K | 0.02% | 397 |
|
|
2019
Q4 | $180K | Buy |
2,500
+980
| +64% | +$70.6K | 0.03% | 384 |
|
|
2019
Q3 | $213K | Buy |
+1,520
| New | +$213K | 0.04% | 357 |
|
|
2019
Q1 | – | Sell |
-395
| Closed | -$37K | – | 705 |
|
|
2018
Q4 | $37K | Hold |
395
| – | – | 0.01% | 484 |
|
|
2018
Q3 | $56K | Buy |
+395
| New | +$56K | 0.01% | 478 |
|